|Day Low/High||8.32 / 8.73|
|52 Wk Low/High||3.69 / 24.00|
Conference Call Scheduled for Wednesday, March 13 at 4:30 p.m. Eastern Time
SAN DIEGO, Feb. 26, 2019 /PRNewswire/ -- Viking Therapeutics, Inc.
Investors in Viking Therapeutics Inc saw new options become available this week, for the March 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VKTX options chain for the new March 15th contracts and identified one put and one call contract of particular interest.
Investors in Viking Therapeutics Inc saw new options begin trading this week, for the January 2021 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 717 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
There are obvious signs that people are trying to put cash to work.
SAN DIEGO, Jan. 2, 2019 /PRNewswire/ -- Viking Therapeutics, Inc.
After two chaotic days, Wall Street is trading relatively calmly, creating opportunities for individual names to show life.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
The most recent short interest data was recently released for the 10/31/2018 settlement date, and Viking Therapeutics Inc is one of the most shorted stocks of the Russell 3000, based on 7.60 "days to cover" versus the median component at 4.44. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.
If you are trying to pick stocks for the longer term it can be quite challenging right now.
Study Achieves Primary Endpoint, Demonstrating Statistically Significant LDL-C Reductions in Patients Receiving VK2809 at Week 12
Conference call scheduled for 4:30 p.m. ET today
What is most interesting about the action today is a spike in the speculative action.
Conference Call Scheduled for Wednesday, November 7 at 4:30 p.m. Eastern Time
I'm simply focusing on individual stocks at this point and am not too concerned about the macro picture.
Just when you thought the worst was over another wave of selling would hit.
One very encouraging sign Friday is relative outperformance by names that have lately been the weakest.
This stock can become much cheaper if there is a major cycle turn occurring.
They include holding a high level of cash, keeping stops tight and being patient.
This is a battleground stock that has made big moves in both directions on earnings in the past.
If you are interested in Square longer term be patient and wait for the drama to end.
VK2809 Treatment Leads to Rapid Reduction in Steatosis, Inflammation and Liver Size in Mouse Model of Glycogen Storage Disease Type Ia (GSD Ia)
Presentation to Highlight Positive 12-Week Data for Novel, Liver-Selective Thyroid Receptor Beta Agonist in Patients with Non-Alcoholic Fatty Liver Disease and Elevated LDL-Cholesterol
It's an interesting story but there are better places for your funds.
Study Achieves Primary Endpoint, Demonstrating Statistically Significant, Dose-Dependent Increases in Lean Body Mass Ranging from 4.8% to 9.1% Following Treatment with VK5211
SAN DIEGO, Sept. 26, 2018 /PRNewswire/ -- Viking Therapeutics, Inc.
It is likely that value buyers will be looking for entry soon as the stock tests the $240 area.
After recent weakness in the biotech sector, here are some names to start watching.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.